James P. O’Callaghan

DARPP-32: Regulator of the Efficacy of Dopaminergic Neurotransmission

Allen A. Fienberg, Noboru Hiroi, P. Mermelstein et al. · Science · 1998 · 526 citations

Life Sciences, Neurobiology, Neuroscience +17

Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse.

James P. O’Callaghan, Diane B. Miller · Journal of Pharmacology and Experimental Therapeutics · 1994 · 411 citations

Pharmacy, Neuroscience, Pharmacology +17

Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson's disease

Krishnan Sriram, Joanna Matheson, Stanley A. Benkovic et al. · The FASEB Journal · 2002 · 361 citations

Life Sciences, Neurobiology, Neuroscience +17

Work, Obesity, and Occupational Safety and Health

Paul A. Schulte, Gregory R. Wagner, Aleck Ostry et al. · American Journal of Public Health · 2007 · 319 citations · Full text

Public Health, Injury Prevention, Ergonomics +16

Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission

Gretchen L. Snyder, Kimberly E. Vanover, Hongwen Zhu et al. · Psychopharmacology · 2014 · 284 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17